检索结果 - Cecilia M. Fenoglio‐Preiser
- Showing 1 - 10 results of 10
-
1
-
2
-
3
-
4
-
5
-
6
Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer 由 Syma Iqbal, Bryan Goldman, Cecilia M. Fenoglio‐Preiser, Heinz‐Josef Lenz, W. Zhang, K. D. Danenberg, Stephen Shibata, Charles D. Blanke
出版 2011Artigo -
7
The RON Receptor Tyrosine Kinase Mediates Oncogenic Phenotypes in Pancreatic Cancer Cells and Is Increasingly Expressed during Pancreatic Cancer Progression 由 Ryan M. Thomas, Kenya Toney, Cecilia M. Fenoglio‐Preiser, Monica P. Revelo-Penafiel, Sunil R. Hingorani, David A. Tuveson, Susan E. Waltz, Andrew M. Lowy
出版 2007Artigo -
8
Phase II Trial of Erlotinib in Gastroesophageal Junction and Gastric Adenocarcinomas: SWOG 0127 由 Tomislav Dragovich, Sheryl McCoy, Cecilia M. Fenoglio‐Preiser, Jiang Wang, Jacqueline Benedetti, Amanda F. Baker, Christopher B. Hackett, Susan G. Urba, Ken S. Zaner, Charles D. Blanke, James L. Abbruzzese
出版 2006Artigo -
9
Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation 由 Craig J. Burd, Christin E. Petre, Lisa M. Morey, Ying Wang, Mónica P. Revelo, Christopher A. Haiman, Shan Lu, Cecilia M. Fenoglio‐Preiser, Jiwen Li, Erik S. Knudsen, Jiemin Wong, Karen E. Knudsen
出版 2006Artigo -
10
Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S020... 由 Philip A. Philip, Jacqueline Benedetti, Christopher L. Corless, Ralph Wong, Eileen M. O’Reilly, Patrick J. Flynn, Kendrith M. Rowland, James N. Atkins, B. Mirtsching, Saul E. Rivkin, Alok A. Khorana, Bryan Goldman, Cecilia M. Fenoglio‐Preiser, James L. Abbruzzese, Charles D. Blanke
出版 2010Artigo
相关主题
Cancer
Internal medicine
Medicine
Oncology
Colorectal cancer
Biology
Colonoscopy
Epidermal growth factor receptor
Gastroenterology
Adenocarcinoma
Cancer research
Carcinoma
Chemotherapy
Clinical trial
Confidence interval
Gemcitabine
Pancreatic cancer
Pathology
Adenoma
Adenomatous polyps
Androgen receptor
Angiogenesis
Breast cancer
Caffeine
Carcinoembryonic antigen
Cell biology
Cell cycle
Cell growth
Cetuximab
Cigarette smoking